Herbal IQ

04/23/2026

A Federal Shift on Cannabis Has Arrived… But Iowa Needs to Pay Close Attention.

This is one of the most important cannabis policy changes in decades. In April 2026, the federal government officially reclassified state-licensed medical cannabis to a less restrictive category.

👉 That means recognition of medical value
👉 More research opportunities
👉 Potential financial relief for medical operators

On paper, this is progress. But here’s the honest truth…For many Iowans, nothing changes overnight.

Patients are still facing:
• Limited access
• High costs
• Ongoing confusion

And there’s a bigger issue that’s not being talked about enough. While federal policy is moving toward medical cannabis acceptance, Iowa has taken a more restrictive approach to h**p-derived products.

👉 One system is opening up
👉 The other is tightening

That creates real tension for:
• Patients trying to find safe, effective options
• Retailers navigating constant change
• Policymakers balancing safety, access, and public health

💭 So where do we go from here?

• Will Iowa expand its medical cannabis program?
• What happens next with h**p-derived cannabinoids?
• Will access actually improve for the people who need it most?

This isn’t about hype. This is about real people, real policy, and the future of cannabis in Iowa. I break it all down in a new blog below
👉 https://herbal-iq.com/blog/

Let’s have an honest conversation. I’d genuinely like to hear your thoughts.

**pPolicy

04/17/2026

Iowa H**p & Cannabis in 2026… here’s the honest reality.

There’s a lot being said right now, but when you step back and look at what’s actually happening, the picture becomes much clearer.

Iowa isn’t expanding cannabis policy right now…
it’s refining and tightening what already exists.

We have:
• A limited medical program under Chapter 124E
• A highly regulated h**p market shaped by HF 2605
• Strict THC limits (4mg per serving / 10mg per container)
• No adult-use cannabis market

And while there’s been talk around a 15% h**p excise tax, that proposal (HSB 694 → HF 2676) hasn’t moved forward in a clean, active form… but it clearly signals where policy conversations are heading.

At the same time, the only bill with real traction is the expansion of medical dispensaries (HF 990 / SF 399), a practical step to improve patient access.

But here’s the piece that really matters…

Federal policy may become the biggest driver of change next.

There’s growing momentum to redefine h**p, potentially shifting to total THC (including THCA) and restricting certain product categories nationwide.

If that happens, the impact could be felt faster than anything happening at the state level.

Plain and simple:
• Iowa is tightening, not expanding
• The h**p market remains legal, but highly restricted
• Federal decisions could reshape the entire landscape

This is a moment to stay informed, stay aligned, and stay engaged.

Because the best outcomes happen when real voices are part of the conversation early.

If you want a deeper breakdown, I put together a full overview here:
👉 https://herbal-iq.com/

We’ll continue sharing updates in our “In The News” section as things evolve.

Curious what others are seeing right now, especially around product availability, customer behavior or policy conversations in your area.

04/13/2026

I’ve learned something the hard way: you can’t build in this industry alone.

That’s why I’m inviting you to our Midwest Virtual Networking Call
📅 Wed, April 15
🕕 6PM CST

It’s a simple hour to meet good people, build relationships, and stay connected to what’s happening across cannabis and h**p, including the legislative realities that impact all of us.

Comment CALL and we’ll send you the registration link.

03/31/2026

If you’re working in cannabis or h**p, you already know how fast the landscape can change. That’s why community matters.

Join us for a Midwest Virtual Networking Call on Wed, April 15 at 6PM CST hosted through The Cannabis Chamber of Commerce. We’ll connect with professionals across the region, talk through current industry topics (including legislation), and share how to get involved in leadership and future in person events.

Hosted with support from Herbal IQ Education & Consulting, where we’re committed to clear, evidence based education and responsible communication in this space.

Comment CALL for the registration link.

**pProfessionals **pIndustry

03/17/2026

New research caught my eye: a teacher-rated study looked at ADHD-related symptoms in children and young adults with autism using a CBD-rich cannabis extract over 3–6 months.

Some teacher-rated measures improved, but this was open-label research (no placebo), so it’s early evidence, not proof. If you want the clear breakdown, context, and safety guardrails, become a member at Herbal IQ Education & Consulting to access the full study review and ongoing research updates.

Disclaimer: Educational only. Not medical advice. Pediatric cannabinoid use should only be considered with a licensed clinician where legal.

02/27/2026

Last call for Muscle MX.

Our final sale on Muscle MX products wraps up this Saturday, February 28th, and inventory is getting low.

If you’ve been meaning to grab your favorite topical, now’s the time to stop in and check what’s still available.

Limited stock. Offer ends Saturday.
Message us or visit the store for details.

Disclaimer: For adult use only where permitted by law. This post is for informational and promotional purposes only and is not medical advice. Product availability may vary while supplies last.

02/26/2026

There’s a lot of noise in the h**p conversation right now.

But at the heart of it, this really comes down to a few basic questions:

* Are products clearly labeled?
* Are the rules understandable?
* Are consumers protected?
* Are responsible businesses being treated fairly?

A recent policy statement from the Society of Cannabis Clinicians pushes for a more thoughtful approach to h**p regulation, one that supports public health, product transparency, accountability and access.

That is the kind of conversation I believe we should be having more often.

Because good policy should not create more confusion. It should create more clarity.

If you could change one thing about h**p regulation right now, what would it be?

Disclaimer: Educational content only. Not legal or medical advice. Always follow local laws and regulations.

**pEducation

02/23/2026

Cannabis wasn’t always treated like a “fringe” topic.

It was listed as an official medicine in the U.S. Pharmacopeia from 1850–1942. That’s a big deal, because the Pharmacopeia is basically the historical record of what American medicine recognized and standardized at the time.

So how did we go from “official medicine” to decades of stigma and confusion?

That’s the story I’m unpacking in my newest Herbal IQ blog, and it’s a reminder that today’s cannabis debate is as much about history and policy as it is about science.

If you want the short version: history doesn’t prove what works for you today, but it absolutely shows this conversation deserves seriousness and evidence, not hype.

Want the link to the blog? Comment “USP” and I’ll drop it.

👉Disclaimer: Educational content only. Not medical advice. Always follow local laws and consult a licensed clinician for personal medical decisions.

02/15/2026

02/11/2026

Ever wonder what actually makes THC and CBD work so differently in your body? It comes down to how each one interacts with your endocannabinoid system — and why dose matters more than most people think.

Here's what we break down in this video:
🔹 THC binds directly to CB1 receptors in the brain, which is why it can influence mood, sleep, appetite, pain signaling and perception — and why a little can feel helpful while too much can feel overwhelming.
🔹 CBD works more indirectly. Rather than binding strongly to CB1, it tends to influence how your body uses its own endocannabinoids. That's why it can feel more subtle, and why consistency is key when evaluating it.
🔹 There's no one-size-fits-all cannabinoid or dose. Your goals, your sensitivity, your product type and timing all shape the outcome. Guessing can backfire — education makes the difference.

Want to go deeper? Grab our free ebook, The Essential Guide to H**p & Cannabinoid Wellness: Science, Safety & Smart Choices at herbal-iq.com.

Follow Herbal IQ for more of this series, and share this with someone who's curious about how cannabinoids actually work!

02/09/2026

A study summary I’ve been thinking about lately, especially because it touches one of the toughest realities in mental health care: Treatment resistant depression.

A recent analysis from the UK Medical Cannabis Registry followed patients prescribed cannabis based medicinal products and tracked outcomes for up to 24 months. The researchers reported improvements in patient reported measures of depression severity, anxiety, sleep quality and health related quality of life, with the biggest changes showing up early and then generally persisting over time.

A few important notes before anyone runs with a headline:

This is observational registry data, not a randomized controlled trial. It can show association, not prove that cannabis “treats” depression. We also don’t get the full picture on product composition, dosing or the many other variables that shape mental health outcomes over two years.

Still, I think this kind of real world evidence matters, for one big reason:

It reminds us that patients with complex, persistent depression are actively searching for relief and we owe them honest research, not hype and not stigma.

What I’d love to see next (and what we should be pushing for):

More rigorous trials that separate outcomes by THC to CBD ratios, dose ranges, routes of administration, comorbid anxiety, sleep disruption, trauma history and medication profiles. If we want clarity, we need study designs that match the real world.

If you’re a clinician, researcher, or someone with lived experience, I’m curious:

What’s the single most important question you want future cannabis and mental health research to answer?
References:
NORML summary: https://norml.org/news/2026/01/15/study-cannabis-treatment-provides-sustained-relief-for-patients-with-treatment-resistant-depression/

Journal of Affective Disorders paper: https://www.sciencedirect.com/science/article/pii/S0165032725025728

👉 Disclaimer: Educational content only. Not medical advice. Cannabis may worsen symptoms for some people and can interact with medications. If you’re struggling or in crisis, please reach out to a licensed mental health professional or local emergency resources.

02/06/2026

New research caught my eye this week and it’s worth a careful look.

A large dataset study (UK Biobank, adults 40–77) found associations between lifetime cannabis use and differences in brain volume and cognitive test performance. That does not prove cause and effect, but it does add nuance to the conversation and highlights why better research matters.

If you’ve been frustrated by the “cannabis is always bad” vs “cannabis fixes everything” debate, this is a good example of why we need to stay grounded in data, context, and individual factors like age, dose, product type and health history.

Want me to break down what the study actually measured (and what it didn’t), in plain language?

Comment “BRAIN” and I’ll post a quick, simple explainer.



👉Disclaimer: Educational content only. Not medical advice. Cannabis laws vary by state. If you choose to use cannabinoid products, consider discussing with a licensed clinician, especially if you take medications or have a medical condition.
________________________________________